Evidence map›Paper›PMID 39176127›Full record

ReviewNeurology. Genetics2024

Clinical Approach to Genetic Cerebral Arteriopathy in the Adult Patient With Ischemic Stroke.

Eliot N Haddad, Pranav Kumar, Galen Shearn-Nance, G Abbas Kharal, Andrew Dhawan

Abstract readReview
In one paragraph

Review in Neurology. Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eliot N HaddadFrom the Cleveland Clinic Lerner College of Medicine (E.N.H., A.D., G.A.K.); School of Medicine (P.K., G.S.-N.), Case Western Reserve University; and Neurological Institute (A.D., G.A.K.), Cleveland Clinic, OH.
Pranav KumarFrom the Cleveland Clinic Lerner College of Medicine (E.N.H., A.D., G.A.K.); School of Medicine (P.K., G.S.-N.), Case Western Reserve University; and Neurological Institute (A.D., G.A.K.), Cleveland Clinic, OH.ORCID https://orcid.org/0009-0009-2986-4332
Galen Shearn-NanceFrom the Cleveland Clinic Lerner College of Medicine (E.N.H., A.D., G.A.K.); School of Medicine (P.K., G.S.-N.), Case Western Reserve University; and Neurological Institute (A.D., G.A.K.), Cleveland Clinic, OH.
G Abbas KharalFrom the Cleveland Clinic Lerner College of Medicine (E.N.H., A.D., G.A.K.); School of Medicine (P.K., G.S.-N.), Case Western Reserve University; and Neurological Institute (A.D., G.A.K.), Cleveland Clinic, OH.ORCID https://orcid.org/0000-0001-6074-1028
Andrew DhawanFrom the Cleveland Clinic Lerner College of Medicine (E.N.H., A.D., G.A.K.); School of Medicine (P.K., G.S.-N.), Case Western Reserve University; and Neurological Institute (A.D., G.A.K.), Cleveland Clinic, OH.ORCID https://orcid.org/0000-0002-5027-1277

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic arteriopathies leading to stroke in adults constitute a diverse group of cerebrovascular disorders with distinct etiologies, pathophysiologic mechanisms, and clinical presentations. As imaging modalities better delineate subtle changes in cerebral vasculature and access to genetic testing increases, the detection rate for these conditions is expected to rise, particularly among young adults with idiopathic cerebral arteriopathy and stroke. Adults with stroke in the setting of a genetic cerebral arteriopathy often present with few traditional stroke risk factors and, in certain cases, have characteristic clinical features, cerebrovascular imaging findings, and often concurrent systemic vasculopathy, such as aortopathy, which are important to recognize. Given that there are over 50 recognized genetic cerebral arteriopathies that can cause ischemic and hemorrhagic stroke in young adults, it can be a significant diagnostic challenge for the practicing neurologist when faced with a genetic cerebral arteriopathy, because clinical algorithms for a systematic approach to genetic cerebral arteriopathies are lacking. In this review, we present a phenotype-driven, clinically oriented algorithm to guide the diagnostic workup when suspecting a genetic cerebral arteriopathy in an adult patient while highlighting the genetic basis of each disease, molecular mechanisms, clinical manifestations, diagnostic approaches, and emerging therapeutic strategies. Moreover, given the lack of widely available gene panels for diagnostic germline testing for genetic cerebral arteriopathies, we propose key genes to be tested and focused on in each clinical scenario, to better decipher the underlying diagnosis in these rare conditions.

Identifiers

PMID39176127
PMCPMC11341007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.